Sarepta Therapeutics stockSRPT
Sarepta Therapeutics trades at $17.57, 28.8% below its 52-week high (Jan 26, 2026). The price is below its 50- and 200-day averages, a downtrend. −18.4% year to date, −5.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for SRPT — after you log in
Open the terminalFrequently asked questions about Sarepta Therapeutics
What is the Sarepta Therapeutics stock price?
At the close on Nov 5, 2026: $17.57 (−7.48% on the day). 52-week high: $24.68 on Jan 26, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Sarepta Therapeutics report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −103% year over year, revenue −34%.
Does Sarepta Therapeutics pay dividends?
No, Sarepta Therapeutics does not pay dividends.
Where does Sarepta Therapeutics trade and how to buy it?
Ticker SRPT, exchange Nasdaq, listed since 1997. You can buy it through a broker with access to US exchanges.
Should I buy Sarepta Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for SRPT are in the terminal after you log in.